Sanofi searching for new R&D boss after John Reed revelation

French drugmaker Sanofi (Euronext: SAN) is searching for a new global head of R&D after the role’s current incumbent John Reed announced he was off to pursue an undisclosed opportunity outside the company.

Since joining Sanofi in 2018, Dr Reed is credited for laying the foundation for the company’s R&D transformation, helping to reshape the group’s discovery and development of therapeutics and focusing efforts on first and best in class medicines, while managing the integration and development of new technology platforms and partnerships, and driving R&D productivity.

While an internal and external search has already started to identify the successor to Dr Reed, Dietmar Berger, has agreed to take the leadership of the team ad interim.